Since about 1990, the PSA blood test has been dramatically over-utilized as a screening test for prostate cancer. That changed in 2012 when a federal panel advised against its routine use. Now, a urologist says, let s try PSAs again. Really?
prostate cancer
The American College of Physicians has come out with a report that questions the value of current screening recommendations and protocols. The report, released yesterday in the Annals of Internal Medicine, calls into question whether current screening practices exhibit high
Prostate cancer is the most common type of cancer in men. In 2015, there are expected to be 220,800 new cases of prostate cancer in the United States. Prostate cancer is the second leading cause of cancer death in American men (lung cancer is by far the leading cancer killer).
A study published in this month s Journal of Urology outlines a better than 90% effectiveness of dogs at detecting prostate cancer by sniffing a patient s urine. The researchers, based in Italy, trained two 3-year-old female German Shepherds for 5 months using operant
Sixty-five percent of those diagnosed with invasive cancer during 2003 to 2010 survived for five years or longer after their diagnosis, according to a recent report from the CDC. This is an increase from 64 percent fr
The latest in health news: Vitamin B supplementation could help reduce first stroke in adults with hypertension, strength training for the elderly key to good health, and cancer survival rates improving across the board
In an opinion piece published in today s New York Times, Dr. Richard J. Ablin addresses the serious problems with prostate cancer screening. Dr. Ablin discovered the prostate-specific antigen, or PSA, in 1970 (although widespread PSA screening didn t become routine until the 1990s) and it
In November - or as it is now more commonly being referred to Movember - millions of men commit to grow moustaches to raise awareness of men s health issues, such as
A new, large cohort analysis from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, indicates that
Prostate-specific antigen (PSA) screening is a commonly ordered test, despite it s being a highly debated public health practice, and despite recent recommendations which continue to condemn the screening strategy. However, despite the US Preventive Services Task Force s (USPSTF) and other experts recommendations against routine
A new type of genetic analysis of prostate cancers from biopsies seems to give a better assessment of prognosis than the standard methods. What implications might this have for the future of prostate cancer prognosis and follow-up?
A recent study from the Harvard School of Public Health suggests vasectomies are associated with an increased risk of advanced or lethal prostate cancer.